Autolus Therapeutics plc (AUTL) stock forecast and price target
Price $1.17 · data as of November 13, 2026
12-month price target
Average target$8.36
Upside / downside+614.7%
Analysts8
ConsensusStrong buy
Low $5.00Average $8.36High $11.00
Gold marker: average target · white marker: today’s price ($1.17)
Analyst ratings
Strong buy 1Buy 8Hold 0Sell 0Strong sell 0
Earnings and revenue estimates
| Period | EPS estimate | EPS growth | Revenue estimate |
|---|---|---|---|
| Current fiscal year ends December 31, 2026 | $-0.80 | +26.1% | $152M |
| Next fiscal year ends December 31, 2027 | $-0.57 | +29.1% | $197M |
| Quarter after ends December 31, 2026 | $-0.18 | +48.0% | $42M |
Consensus of the analysts covering Autolus Therapeutics, updated daily. In the last 30 days 0 estimates were raised and 2 lowered.
Frequently asked questions
What is the Autolus Therapeutics stock price target?
The average 12-month target from 8 analysts is $8.36, 614.7% above the current price of $1.17 Targets range from $5.00 to $11.00.
Is Autolus Therapeutics a buy according to analysts?
The consensus rating is “Strong buy” (1 strong buy, 8 buy). Ratings are opinions, not guarantees; this is not investment advice.
How much is Autolus Therapeutics expected to earn?
Analysts expect EPS of $-0.80 for the fiscal year ending December 31, 2026 and $-0.57 the year after.
Analyst consensus estimates and price targets, updated daily. Forecasts can be wrong; this is information, not investment advice.